MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced the successful closing of a €55 million (US$64 million) Series B financing round. The round was led by French pharmaceutical group Biocodex and included strong participation from German-based ATHOS, as well as new investor BNP Paribas Fortis Private Equity and existing investors SFPIM, Ackermans & van Haaren (AvH), OMX Europe Ven...

Moody’s Corporation (NYSE:MCO) announced today that it intends to secure a majority equity stake in Middle East Rating & Investors Service (MERIS – an affiliate of Moody’s), a domestic credit rating agency in Egypt. The transaction extends the long-established partnership between the companies and deepens Moody’s presence in the Middle East and Africa, reaffirming its commitment to contribute to the ongoing development of local capital markets across the globe. “We are excited to strength...

Galderma (SIX: GALD), the dermatology category leader, today announced it will unveil updates from its portfolio at the 34th European Academy of Dermatology and Venereology (EADV) congress, taking place in Paris, September 17-20, 2025. Highlighting its commitment to addressing skin conditions across the dermatology spectrum, Galderma will present 12 abstracts, including data on sensitive skin, prurigo nodularis, and atopic dermatitis, and host a variety of events – from industry hubs on sensiti...

Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded an engineering, procurement and construction (EPC) contract by Equinor for a 12-well, all-electric Subsea Production System (SPS) in the Fram Sør field, offshore Norway. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250825924465/en/SLB OneSubsea will deliver 4 subsea templates and 12 all-electric subsea trees, elimina...